Fisher & Paykel Healthcare renews key US distribution deal
Deal with medical tech giant puts Fisher & Paykel Healthcare's respiratory care products in US hospitals.
Healthcare products maker Fisher & Paykel Healthcare (FPH) has renewed a key distribution deal that gets its products into US hospitals.
Renewal of a 25-year-old agreement continues to give global medical tech giant CareFusion exclusive distribution rights for FPH’s respiratory care products in US hospital market.
CareFusion will continue to be the US distributor of FPH’s portfolio of respiratory consumable products that help with the treatment of obstructive sleep apnea.
CareFusion has its own respiratory consumables business under the AirLife brand.
Shares in FPH last traded at $2.11, having fetched between $2.09 and $3.19 in the last year.
NBR staff
Thu, 09 Feb 2012
Thu, 09 Feb 2012
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Fisher & Paykel Healthcare renews key US distribution deal
18768